Ultra Clean Holdings, Inc. (UCTT) Misses Q1 EPS Views; Issues Q2 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts UCTT Hot Sheet
Price: $45.32 +1.93%
Revenue Growth %: +63.6%
Financial Fact:
Research and development: 2.45M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: +63.6%
Financial Fact:
Research and development: 2.45M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) reported Q1 EPS of $0.06, $0.11 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $110.6 million versus the consensus estimate of $107.1 million.
Ultra Clean Holdings, Inc. sees Q2 2012 EPS of $0.16-$0.19, versus the consensus of $0.18. Ultra Clean Holdings, Inc. sees Q2 2012 revenue of $100-$105 million, versus the consensus of $106.8 million.
For earnings history and earnings-related data on Ultra Clean Holdings, Inc. (UCTT) click here.
Ultra Clean Holdings, Inc. sees Q2 2012 EPS of $0.16-$0.19, versus the consensus of $0.18. Ultra Clean Holdings, Inc. sees Q2 2012 revenue of $100-$105 million, versus the consensus of $106.8 million.
For earnings history and earnings-related data on Ultra Clean Holdings, Inc. (UCTT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Bristol Myers Squibb MS CAR T therapy data shows patients off DMTs
- AI-powered cyber threats light a fire under cybersecurity stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
